Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of MLD10 in the Prevention of Migraine Headache in Adults
Conditions
Interventions
MLD10
Placebo
Locations
9
United States
The Research Center of Southern California
Carlsbad, California, United States
San Francisco Clinical Research Center
San Francisco, California, United States
Physician Associates of Florida Research Department
Oviedo, Florida, United States
Dr. B. Abraham, P.C.
Snellville, Georgia, United States
Westside Family Medical Center, P.C.
Kalamazoo, Michigan, United States
StudyMetrix Research
City of Saint Peters, Missouri, United States
Start Date
March 1, 2015
Primary Completion Date
June 1, 2017
Completion Date
June 1, 2017
Last Updated
October 9, 2020
NCT06735833
NCT06241313
NCT06810505
NCT07071506
NCT07018713
NCT06641466
Lead Sponsor
Pharmalyte Solutions LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions